Wealth Enhancement Advisory Services, LLC Madrigal Pharmaceuticals, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 701 shares of MDGL stock, worth $308,418. This represents 0.0% of its overall portfolio holdings.
Number of Shares
701Holding current value
$308,418% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding MDGL
# of Institutions
358Shares Held
23.3MCall Options Held
738KPut Options Held
473K-
Janus Henderson Group PLC London, X02.19MShares$964 Million0.34% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.09MShares$919 Million32.86% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$877 Million9.27% of portfolio
-
Baker Bros. Advisors LP New York, NY1.98MShares$869 Million6.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$826 Million0.01% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $7.52B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...